OTC antiseptic product firms are making the most of a recent FDA rulemaking that removes 24 ingredients from approval for use under a monograph by focusing on six substances that remain available but face potential exclusion.
A final rule FDA published in December 2017 applies only the generally regarded as safe and effective (GRASE) status for to antiseptic ingredients in products intended for use by health care professionals in hospitals or similar venues. Effective Dec
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?